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Protocol
AbstrACt
Introduction Postoperative delirium (POD) is a common 
complication in elderly patients, characterised by a 
fluctuating course of altered consciousness, disordered 
thinking and inattention. Preliminary research has linked 
POD with persistent cognitive impairment and decreased 
quality of life. However, these findings maybe confounded 
by patient comorbidities, postoperative complications 
and frailty. Our objective is to determine whether POD is 
an independent risk factor for persistent impairments in 
attention and executive function after elective surgery. 
Our central hypothesis is that patients with POD are more 
likely to have declines in cognition and quality of life 1 year 
after surgery compared with patients without POD. We aim 
to clarify whether these associations are independent of 
potentially confounding factors. We will also explore the 
association between POD and incident dementia.
Methods and analysis This study will recruit 200 
patients from the ongoing Electroencephalography 
Guidance of Anesthesia to Alleviate Geriatric Syndromes 
(ENGAGES) study. Patients who live ≤45 miles from the 
study centre or have a planned visit to the centre 10–16 
months postoperatively will be eligible. Patients with POD, 
measured by the Confusion Assessment Method, will be 
compared with patients without delirium. The primary 
outcome of cognitive function and secondary outcomes 
of quality of life and incident dementia will be compared 
between cohorts. Cognition will be measured by Trails 
A and B and Stroop Color and Word Test, quality of life 
with Veteran’s RAND 12-item Health Survey and incident 
dementia with the Short Blessed Test. Multivariable 
regression analyses and a Cox proportional hazards 
analysis will be performed. All results will be reported with 
95% CIs and α=0.05.
Ethics and dissemination The study has been approved 
by the Washington University in St. Louis Institutional 
Review Board (IRB no 201601099). Plans for dissemination 
include scientific publications and presentations at 
scientific conferences.
trial registration number NCT02241655.
bACkground 
Since Bedford’s 1955 case series suggesting 
an association between surgical intervention 
and cognitive impairment, there has been 
growing concern among the public that 
cognitive decline is a common consequence 
of surgery.1 This pervasive view continues to 
concern patients and their families, fuelled 
by anecdotal evidence and media coverage. 
Postoperative cognitive decline (POCD) has 
been a growing topic for scientific investiga-
tion after several studies were published by 
the International Study of Post-Operative 
Cognitive Dysfunction group. While several 
influential studies demonstrated early POCD 
lasting up to 3 months, the persistence of this 
cognitive decline has been controversial.2–6 
Importantly, the population of Americans 
older than 60 years is projected to double 
over the next 30 years,7 and many will require 
strengths and limitations of this study
 ► Postoperative intermediate term cognitive function 
and quality of life are important patient-centred 
outcomes.
 ► Analysis will include salient patient characteristics, 
including preoperative cognition, comorbid condi-
tions and frailty.
 ► Study sample will consist of an understudied popu-
lation in clinical research.
 ► Potential for loss to follow-up and non-response 
bias.
 ► We cannot determine whether cognitive function de-
viates from the preoperative trend, without multiple 
preoperative cognitive assessments to establish a 
trajectory.
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surgery. Acute and long-term cognitive changes related 
to surgical intervention are particularly distressing to 
patients and their families. Therefore, clarification of 
cognitive outcomes would assist patients and practitioners 
in making an informed decision about the relative risks 
and benefits of proceeding with elective surgery.
Literature search and review
A systemised literature review was conducted with the 
help of a librarian experienced in a systemic review (see 
Acknowledgements). Ovid Medline was searched for 
studies published between 1981 and September 2016 
using the query: Postoperative or after surgery AND 
Delirium AND Cognitive function or dementia AND 
Elderly AND Long-term or intermediate term or follow 
up or cohort studies or retrospective studies. Articles in 
English or with English translation were considered. JZC 
and RT reviewed the 301 search results and found 28 arti-
cles that were relevant to our clinical question. Out of the 
28 relevant articles, 21 (75%) showed significant result in 
the relationship between postoperative delirium (POD) 
and intermediate-term to long-term cognitive decline 
(see online supplementary appendix A). These seem to 
suggest a high pretest probability in studying the ability 
of POD to predict intermediate-term cognitive decline. 
However, these studies are heterogeneous in the study 
design, selected surgical patient population and outcome 
measurement tools complicating the synthesis of the 
systemic search to draw conclusions.
POD is a common complication for surgical patients 
over the age of 60 years.8 It is a neurological syndrome 
characterised by acute and fluctuating disturbances in 
awareness and attention that represent a change from 
baseline; in addition to these cardinal features, the 
diagnosis of delirium requires at least one additional 
cognitive symptom and the absence of medical condi-
tions that might explain these disturbances. Although 
usually transient, POD has been associated with several 
salient adverse outcomes, including mortality, prolonged 
intensive care unit (ICU) stay and persistent cognitive 
decline.9–12 One prospective cohort study of cardiac 
surgery patients suggested that patients experiencing 
POD had prolonged cognitive impairment at 1 year and 
those with a longer duration of delirium had slower 
recovery.12 However, after adjusting for baseline differ-
ences in cognitive function, there was no significant 
difference compared with controls. The same study also 
demonstrated that mild cognitive impairment preoper-
atively may predispose patients to delirium; thus, POD 
may be exposing patients who are already experiencing 
subclinical cognitive decline or those who have an under-
lying vulnerability to cognitive decline. Another study 
in orthopaedic surgery patients found no association 
between POD and cognitive decline at 3 months.13 While 
several studies have suggested that POCD can persist past 
6 months after surgery,2 14 others have demonstrated a 
transient early decline with later recovery.4 5 Furthermore, 
there is conflicting evidence regarding the long-term 
cognitive trajectories of postoperative patients, with some 
suggesting overall improvement and others suggesting 
overall decline.15 16 POD has been posited as a risk factor 
for lasting decline; however, few articles have addressed 
the association between POD and persistent POCD 
(arbitrarily defined as lasting >6 months). A prospective 
matched controlled survey with an average of 30 month 
follow-up demonstrated that dementia or mild cognitive 
impairment was diagnosed in 77.8% of the surviving hip 
surgery patients with POD, almost doubling the 40.9% 
rate of control patients (relative risk=1.9, 95% CI 1.1 to 
3.3). However, the study was underpowered to evaluate 
the long-term cognitive function, as the power calcula-
tion was based on the original study and no intermediate 
assessments were made to track patients’ cognitive func-
tion.17 Another prospective cohort study followed patients 
over 36 months and found that patients with POD initially 
had cognitive decline with a transient recovery, but then 
exhibited an accelerated pace of long-term cognitive 
decline when compared with controls.18 Overall, the 
results of these studies suggest an association between 
POD and persistent cognitive impairment; however, 
compelling data supporting an independent association 
are lacking. Many of these studies also do not consider 
the duration of delirium, which may portend long-term 
cognitive decline.19 20
Pre-existing dementia or cognitive impairment is a 
known risk factor for POD,8 and several studies suggest 
an association between POD and dementia. One study in 
elderly orthopaedic surgery patients reported a relative 
risk of dementia in patient with POD of 10.5 compared 
with those without POD.21 A recent study demonstrated 
a similar association in elderly cardiac surgery patients.22 
However, it remains unclear whether POD causes, accel-
erates or signifies an underlying vulnerability to cognitive 
impairment, and thus further investigation is warranted.
In addition to cognitive outcomes, quality of life and 
functional capacity are also important patient-centred 
outcomes that require further investigation. While one 
study found that elderly surgical patients tended to have 
long-term cognitive and functional decline compared 
with non-surgical patients,23 few studies have examined 
the association between cognitive function and quality 
of life or activities of daily living. One prospective study 
over a 10-month period demonstrated that delirium was 
an independent risk factor for becoming dependent for 
personal activities of daily living after ICU discharge (OR 
2.188, P<0.046) and that patients with POD also demon-
strated a greater decline in Short-Form-36 domains after 
discharge, especially in physical function, vitality and social 
function.24 However, this study could not draw conclu-
sions regarding cognitive function due to lack of data. 
Kastaun et al reported perceived impairment in ability 
to perform activities of daily living 1 year after surgery, 
however did not detect significant cognitive decline at 
that time.25 It remains unclear whether cognitive decline 
results in impaired functional capacity or decreased 
quality of life. In fact, given the variable definitions of 
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POCD, data from previous studies are difficult to inter-
pret. As many of the deficits found in neuropsychiatric 
testing are subtle, it is possible that detected cognitive 
impairment has no clinically significant impact on these 
patient-centred outcomes. Instead of using an arbitrary 
threshold to dichotomise cognitive function as normal or 
impaired, it would be more informative to correlate these 
outcomes with cognitive function as a continuous variable 
or stratified into multiple groups.
At our institution, patient reported postoperative 
outcomes are gathered as part of the Systematic Assess-
ment and Targeted Improvement of Services Following 
Yearlong Surgical Outcomes Surveys (SATISFY-SOS) 
initiative (NCT02032030). Additionally, the ongoing 
randomised controlled trial, Electroencephalography 
(EEG) Guidance of Anesthesia to Alleviate Geriatric 
Syndromes (ENGAGES) study, is evaluating patients for 
POD.26 Using the scaffold provided by these studies, 
we aim to identify whether delirium is an independent 
predictor for intermediate-term cognitive function and 
quality of life.
Justification
The population of older adults is projected to double 
over the next 30 years, and many will undergo elective 
surgery with the hope of overall improvement in health 
and quality of life. POD is a common and potentially 
preventable complication; thus, clarification of its associ-
ation with persistent declines in cognition and quality of 
life will inform perioperative care. Prior studies have not 
demonstrated an association independent of pre-existing 
patient characteristics and perioperative course. The 
proposed study addresses the methodological concerns 
in current literature by: (1) objectively evaluating atten-
tion and executive function with validated cognitive tests, 
(2) obtaining measurements of baseline cognitive func-
tion, (3) conducting statistical analysis which includes 
important potential confounding factors including frailty 
measures and (4) sampling from an unselected surgical 
population. Given that delirium is predominantly a 
disorder of attention and executive function, we will focus 
our investigation on these cognitive domains. The results 
of this study will contribute to the broader understanding 
of postoperative cognitive changes and may help identify 
and provide therapies for susceptible patients earlier to 
ultimately improve outcomes.
As part of the ENGAGES study, patients have been 
enrolling since January 2015, with 804 patients enrolled 
thus far. Over the last year, the ENGAGES research team 
has enrolled approximately 35 patients/month, and has 
gathered baseline cognitive data on a majority of partici-
pants. Preliminary screening suggests about 65% of those 
enrolled in ENGAGES are eligible for the current study. 
Anticipating that half of those contacted will enrol, we 
expect to assess 10–15 patients/month. The scaffold of 




Determine whether the incidence and duration of POD 
predict worse performance on specific cognitive tests at 
approximately 1 year after surgery.
We hypothesise that POD is independently associated 
with poorer performance on tests of attention and exec-
utive function at 1 year after surgery and that patients 
with a longer duration of delirium will have more marked 
cognitive decrement. We will conduct a regression anal-
ysis, including likely contributory variables, to assess the 
association between delirium and cognitive decline at 
approximately 1 year.
Specific aim 2
Evaluate whether the incidence and duration of POD 
predict worse quality of life at approximately 1 year 
postoperatively.
We hypothesise that POD is independently associated 
with decreased quality of life 1 year after surgery and that 
patients with a longer duration of delirium will have more 
marked decrease in health-related quality of life. We will 
conduct a regression analysis, including likely contribu-
tory variables, to assess the association between delirium 
and health-related quality of life at approximately 1 year.
Specific aim 3
Explore whether patients who experience POD are more 
likely to develop dementia within approximately one to 
2 years of their surgery.
We hypothesise that POD is independently associated 
with incident dementia 1–2 years after surgery. We will 
conduct a Cox proportional hazards regression, including 
likely contributory variables, to assess the rate of incident 
dementia approximately 1–2 years after surgery.
study dEsIgn
This prospective cohort study is prespecified substudy 
of the ENGAGES study. The ENGAGES study is a 
randomised clinical trial enrolling approximately 1200 
patients aged 60 years and older who will undergo elec-
tive major surgery at Barnes Jewish Hospital (BJH), 
St. Louis, Missouri, USA.
The parent trial will recruit patients primarily from 
the Center for Preoperative Assessment and Planning 
(CPAP) clinic. Details regarding ENGAGES recruitment 
and methods have been previously published.26 Enrol-
ment in the SATISFY-SOS study,27 is an inclusion criteria 
for participation in ENGAGES. As part of ENGAGES, 
participants will complete a comprehensive baseline 
assessment including cognitive tests, frailty measures and 
screening for delirium and dementia. Postoperatively, 
patients will have daily evaluations for delirium during 
the hospital stay. The current study will retrospectively 
identify 200 participants who reside within approxi-
mately 45 miles from the hospital or those who have a 
planned visit to the hospital between 10 and 16 months 
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postoperatively. Patients diagnosed with delirium postop-
eratively will be compared with those without delirium. A 
prospective intermediate-term postoperative assessment 
will be conducted by a research team member blinded to 
whether the patient developed POD.
study groups
The target population for this study is patients who 
underwent preoperative assessment for elective surgery 
at the CPAP clinic at BJH in St. Louis, Missouri, USA. The 
ENGAGES study is enrolling 1232 patients who are already 
enrolled in the STATISFY-SOS study. Inclusion criteria 
include patients aged 60 years and older, who are compe-
tent to provide informed consent and who are under-
going major elective surgery under general anaesthesia 
with a potent volatile anaesthetic agent that requires a 
minimum stay of 2 days postoperatively (ie, open cardiac 
surgery, open thoracic surgery, major vascular surgery, 
intra-abdominal surgery, open gynaecological surgery, 
open urological surgery, major orthopaedic surgery, 
open hepatobiliary surgery and major ear, nose and 
throat surgery). The ENGAGES study has minimal exclu-
sion, as there are no absolute contraindications to EEG 
monitoring. Exclusion criteria include neurosurgical 
procedures, preoperative delirium, patients who are 
unable to participate adequately in delirium screening, 
including those who are blind, deaf, illiterate or not 
fluent in English, patients with a history of intraopera-
tive awareness during intended general anaesthesia and 
patients who had a second surgery planned within 5 days 
after the index surgery. This prospective study will enrol 
200 patients who are already enrolled in the ENGAGES 
and SATISFY-SOS studies (see online supplementary 
appendix B). In addition to previously described inclu-
sion and exclusion criteria, participants will be included 
in this study if their home residence is ≤45 miles from 
BJH or they have a planned visit to the hospital within the 
specified timeframe. Patients who have not completed 
the baseline cognitive assessment with Trails A, Trails B 
and the Stroop Color and Word Test will also be excluded 
from this study.
rECruItMEnt
As part of the SATISFY-SOS study, patients have given 
informed consent to be contacted by Washington Univer-
sity for follow-up of health-related outcomes up to a year 
after surgery. Eligible participants will be identified by 
chart review and query of the ENGAGES Research Elec-
tronic Data Capture (REDCap) database. A member of 
the research team will contact potential participants by 
telephone approximately 10–16 months after surgery for 
enrolment in this study. Patients may refuse participation 
in the study. If patients agree to participation, written 
consent will be obtained when the patient comes in for 
assessment, prior to any data collection. Patients will then 
be prospectively evaluated with assessments of cognition, 
quality of life and frailty measures, which are described in 
the Data collection section. Meal vouchers will be provided 
for participation. Patients residing within approximately 
45 miles of the hospital, who are willing to participate in 
the study, but unable or unwilling to come to the study 
centre will be offered assessment at home by a member 
of the research team. Additionally, ENGAGES patients 
who have not completed a 1 year dementia screening will 
be contacted by telephone approximately 18–24 months 
after surgery. Phone consent will be obtained to complete 




Routinely obtained baseline assessment in the CPAP 
clinic includes demographic information, a detailed 
medical history, surgical history, medications and phys-
ical examination. As part of SATISFY-SOS and ENGAGES, 
baseline assessment using the Barthel Index, Veteran’s 
RAND 12-item Health Survey (VR-12), Eight-item Inter-
view to Differentiate Aging and Dementia, Short Blessed 
Test (SBT), alcohol sniff test and Personal Health Ques-
tionnaire Depression Scale will be performed. Baseline 
cognitive function will be evaluated by the ENGAGES 
team with the Trails A and B, and the Stroop Color and 
Word Test. Some patients may complete computer-based 
cognitive testing with the National Institutes of Health 
(NIH) toolbox at baseline (described below). Addition-
ally, frailty will be assessed using grip strength, Timed 
Up and Go (TUG) test and obtaining fall history at base-
line. Participants will have daily delirium assessments 
by trained researchers with the Confusion Assessment 
Method in the postoperative period for the duration of 
their hospital stay. Data collected by the ENGAGES team 
will be entered into the Washington University School of 
Medicine REDCap application.18 Perioperative data will 
be retrieved from the hospital’s perioperative electronic 
medical record (EMR; Metavision by iMDsoft, Needham, 
Massachusetts, USA). High-fidelity perioperative data 
are routinely captured from our EMR to an SQL server 
(Microsoft, Redmond, Washington, USA) database. 
These data include Bispectral Index (BIS) values, EEG 
burst suppression durations, laboratory data, intraoper-
ative medications, physiological readings and postopera-
tive recovery parameters. All the data for SATISFY-SOS are 
integrated from various data sources and are stored in a 
single data repository housed in the Department of Anes-
thesiology at Washington University. Table 1 contains 
details regarding variables to be collected for the study.
Cognition
The primary outcome in this study will be a composite 
score from three cognitive tests evaluating attention 
and executive function: Trails A, Trails B and Stroop 
Color and Word Test. These cognitive tests will be 
repeated approximately 1 year after surgery to evaluate 
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intermediate term cognitive function. The research team 
member performing the assessments will be blinded to 
whether the patient developed POD. In addition to the 
above tests, this study proposes to use the Cognition 
Battery of the NIH Toolbox Assessment of Neurological 
and Behavioural Function (http://www. nihtoolbox. org). 
The NIH Toolbox Cognition Battery (Feinberg School 
of Medicine, Northwestern University, Chicago, IL), is a 
comprehensive yet concise standardised computer-based 
assessment battery; we plan to include tasks to evaluate 
attention (Flanker Inhibitory Control and Attention 
Test), episodic memory (Picture Sequence Memory Test) 
and executive function (Dimensional Change Card Sort 
Test and Flanker Inhibitory Control and Attention Test). 
Patients will complete the NIH Toolbox Cognition tests 
above, which takes approximately 10 min to complete. 
The NIH Toolbox Cognition Battery has been validated 
for use across a wide range of ages.28 29 Self-reported cogni-
tive function will be evaluated by the Patient Reported 
Outcomes Measurement Information System (PROMIS). 
PROMIS, funded by the NIH, is a set of highly reliable, 
valid, flexible, precise and responsive assessment tools 
that measure patient–reported health status. PROMIS 
V.1.0-Applied Cognition-General Concerns-Short Form 
4a is comprised four questions about thinking and cogni-
tion. PROMIS V.1.0-Applied Cognition-Abilities-Short 
Form 4a is comprised four questions about memory. Eval-
uation for dementia with the SBT will be completed for 
all patients at baseline, and again between 1 and 2 years 
after surgery. The SBT has been shown to have 95% sensi-
tivity for detecting cognitive dysfunction when compared 
with the Mini-Mental State Examination, and can be 
administered in approximately 3 min, making it an excel-
lent screening tool.30
Quality of life
As part of the ongoing SATISFY-SOS study, patient 
self-reported health-related quality of life information 
will be assessed through the VR-12 at baseline (preop-
eratively) and also 1 year after surgery. The VR-12 was 
derived from the Veterans RAND 36 Item Health Survey 
(VR-36) and contains 12 items relating to quality of life, 
including physical and mental health, as well as specific 
questions about functional status. Physical and Mental 
Health Summary Scores will be calculated. The VR-12 
has been validated and is widely applied as a metric 
for tracking health-related quality of life in the United 
States.31
Functional status
We will assess functional status with the Barthel index for 
Activities of Daily Living and Lawton Instrumental Activi-
ties of Daily Living Scale. The Barthel Index is a measure 
of patient performance in 10 activities comprised of eight 
questions about personal care and two questions about 
mobility. The Lawton Scale assesses independent living 
skills in eight areas of function.
Frailty
Information regarding weight loss, endurance and phys-
ical activity level are routinely collected in the preop-
erative clinic and as part of SATISFY-SOS. We will also 
measure grip strength and the TUG test. Grip strength 
will be assessed with three measurements in the dominant 
hand using a Jamar handheld dynamometer (Lafayette 
Instruments, Lafayette, Indiana, USA). Maximal grip 
strength will be selected for analysis.
data management
A customised database has been developed to facilitate 
data management for this study using the REDCap system. 
REDCap is a secure web-based data capture system avail-
able to research groups receiving support from the Insti-
tute of Clinical and Translational Sciences at Washington 
University. It is maintained by the Washington Univer-
sity Division of Biostatistics with multiple capabilities to 
simplify data management and analysis. These include 
intuitive data entry, data audit and tracking, import of 
externally sourced data and automated data export for 
analysis. REDCap requires unique user identification and 
password combinations for secure access.
stAtIstICAL ConsIdErAtIon
sample calculations
For specific aims 1 and 2, sample size calculations have 
been performed using G*POWER V.3.0.10. Power anal-
ysis for a multiple regression with 15 predictors was 
conducted to determine a sufficient sample size using an 
α of 0.05, a power of 0.9 and a medium effect size (f2=0.1). 
Based on the aforementioned assumptions, the desired 
sample size is 130 patients. We will plan to recruit 200 
patients, which will increase the power for the primary 
outcome and prevent overfitting of the regression model.
For specific aim 3, sample size calculation has been 
performed using PS V.3.1.2. Based on results of a previ-
ously published meta-analysis of four studies investi-
gating the use of BIS-guided anaesthetic administration, 
we conservatively assume an incidence of POD of 25%. 
A previous study has reported the median age at the 
onset of dementia to be approximately 84 years old.32 To 
detect a HR of 2.0 in patients with delirium compared 
with those without delirium, with 80% power and 
α=0.05, we will need 516 patients (129 in the delirium 
group, and 387 in the control group). To account for a 
10% attrition rate, we will recruit 570 patients.
statistical analysis
We will perform and report descriptive statistics (mean 
and SD) for all variables between patients with and 
without the diagnosis of POD. Descriptive statistics 
will include χ2 tests for categorical variables, Student’s 
t-test for normally distributed continuous variables and 
Mann-Whitney U test for non-parametric continuous 
variables.
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Specific aim 1
Determine whether the incidence and duration of POD 
predict worse performance on specific cognitive tests at 
approximately 1 year after surgery.
The primary endpoint of our analysis is cognitive func-
tion 1 year after surgery, as measured by the Trails A and 
B and the Stroop Color and Word Test. Z-scores will be 
calculated for performance for each test and combined 
to form a composite measure. Multivariable regression 
analysis will be used to determine whether the develop-
ment of POD is a predictor variable for cognitive func-
tion, independent from other possible contributory 
factors. POD will be entered as two categorical variables: 
for incidence (present or absent) and for duration (<3 
days POD or ≥3 days POD). The following variables will 
be included in the model: age, sex, American Society of 
Anesthesiologists (ASA) physical score, and Charlson 
Comorbidity Index. The following known or suggested 
risk factors cognitive decline will also be included in the 
model: baseline cognitive function, education level, type 
of surgery, randomisation group, preoperative depres-
sion, preoperative vascular disease, postoperative compli-
cations, composite score on frailty tests and a history of 
falls. We will use a model with backward elimination to 
avoid exclusion of predictors with suppressor effects. 
While cognition will be entered as a continuous variable, 
we will consider a change of 1 SD in cognitive score as a 
minimal clinically important difference.
Specific aim 2
Evaluate whether the incidence and duration of POD 
predict worse quality of life at approximately 1 year 
postoperatively.
The primary endpoint of our analysis is quality of life 
1 year after surgery, as measured by the change in VR-12 
score between preoperative and postoperative assess-
ments. Again, a multivariable regression analysis will be 
performed to evaluate whether the development of POD 
is an independent predictor variable for the change in 
quality of life. POD will be entered as two categorical vari-
ables: for incidence (present or absent) and for duration 
(<3 days POD or ≥3 days POD). The following variables 
will be included in the model: age, sex, ASA physical 
score, Charlson Comorbidity Index, type of surgery, 
randomisation group, preoperative depression, preoper-
ative vascular disease, postoperative complications, cogni-
tive function, composite score on frailty tests and a history 
of falls. As above, we will use a model with backward elim-
ination, to avoid exclusion of predictors with suppressor 
effects. Previous work by our group has calculated the 
minimal clinically important difference for overall VR-12 
quality of life to be 1.4 for improvement and 3.6 for 
deterioration.33
For the above aims, we expect this study to be limited 
by loss to follow-up, estimated to be 50%. Those lost to 
follow-up are likely to have more severe disease or dete-
rioration in health. In order to determine the influence 
of missing data in our analysis, we will also conduct a 
sensitivity analysis. We will calculate the average cognition 
scores of those who declined. We will repeat the above 
models including missing subjects, assuming all patients 
who did not participate had cognitive decline, quantified 
by the average calculated from participants above. Addi-
tionally, to examine whether our sample selection method 
may bias the results, we will compare baseline characteris-
tics of those ENGAGES patients who were eligible for our 
study with those who were not eligible.
Specific aim 3
Explore whether patients who experience POD are 
more likely to become demented within approximately 
1–2 years of their surgery.
The primary endpoint of our analysis is incident 
dementia. A Cox proportional hazards regression will be 
used to explore the likelihood of incident dementia asso-
ciated with POD. POD will be entered as a dichotomous 
variable (absent or present). The following variables will 
be included in the model: age, sex, ASA physical score, 
Charlson Comorbidity Index, preoperative cognitive 
function, type of surgery, randomisation group, preoper-
ative depression, preoperative vascular disease, postoper-
ative complications, and composite score on frailty tests 
and a history of falls.
All statistical analyses will be performed using SAS, 
V.9.4. All other tests will be two sided. By arbitrary conven-
tion, all tests will be two sided and considered statistically 
significant at P<0.05, and all results will be presented with 
estimates and 95%CIs.
prespecified additional analyses and substudies
The primary aim of this study is to determine whether 
POD predicts intermediate-term cognitive impairment. 
However, as a substudy of ENGAGES and SATISFY-SOS, 
several other clinically relevant outcomes can be explored 
as well. SATISFY-SOS systematically collects detailed infor-
mation regarding patient-centred outcomes, including 
patient perceived cognition. Correlation between perfor-
mance on neurocognitive testing and patient perceived 
cognition would be interesting and useful clinically. 
Furthermore, the information regarding patients’ charac-
teristics will allow exploration of risk factors for interme-
diate-term cognitive impairment. To investigate effects on 
memory, we will perform a secondary analysis comparing 
the results of the SBT. Lastly, as part of ENGAGES, some 
patients will have baseline NIH Toolbox cognitive testing, 
allowing description of long-term cognitive trajectories as 
evaluated by these tests.
Limitations
This study contains several limitations. First, of most 
concern is the potential for non-response bias if patients 
who do not participate are not a random subset of those 
contacted. We will attempt to minimise the non-re-
sponse rate by offering to visit patients at their homes if 
patients are unwilling to come to the study centre. We 
expect that those lost to follow-up would be more likely to 
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have more severe disease or health deterioration, poten-
tially affecting cognitive function. We will thus conduct 
appropriate sensitivity analyses to determine how missing 
outcomes data could alter the findings of our study. 
Second, with an observational study, we cannot estab-
lish a causal relationship between POD and persistent 
declines in cognitive and quality of life. If an indepen-
dent relationship is found, we shall not be able to disam-
biguate whether POD in some way causes persistent 
decline in these outcomes, or whether it is a sign of 
underlying vulnerability. However, since it is not possible 
to randomise patients to experience delirium, this limita-
tion might be inevitable. Third, since patients in this study 
are recruited from a single tertiary care centre, the study 
sample may not be representative of surgical patients in 
general. While patients from a tertiary care centre tend to 
have higher comorbid disease burden than the general 
surgical population, including comorbidities in the statis-
tical model will account for these differences. Finally, 
while we have baseline cognitive assessments, we do not 
have preoperative cognitive trajectories, and thus cannot 
determine whether the results of cognitive function tests 
are a deviation from the preoperative trend.
CoMpLIAnCE
subject compliance
The exposure of this study is postoperative delirium, 
so no monitoring of exposure compliance is necessary. 
Methods to improve completion of 1 year cognitive testing 
are described in the Limitations section.
Withdrawal of subjects
Subjects may be withdrawn from the study only if 
requested by the patient. The reason for withdrawal is 
recorded by the team’s clinical project specialist.
Ethical considerations
Written, informed consent is obtained from all partic-
ipants. As described in the Study groups section, no 
special allowances are made for patients who are blind, 
deaf, illiterate or not fluent in English. Participants may 
withdraw from the study at any time.
Finance and insurance
Since this study involves only cognitive testing and surveys, 
it involves no more than minimal risk to the patients. 
Finance details, insurance details and cover for negligent 
and non-negligent harm are, therefore, not relevant in 
this study.
reporting and dissemination
Results of this study will be published in a scientific journal. 
Participants will only be notified individually if discoveries 
are made that directly impact their health. We intend to 
make deidentified individual participant data used to obtain 
the results reported from this study available to researchers 
providing a study proposal between 3 months and 5 years 
after article publication. This study protocol, the statistical 
analysis plan and analytic code will also be available.
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